Category
Services
Modalities
Indications
Phases
Sourcing
Locations
Certifications
Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research, Device & Combination Product Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Peptide, Vaccine
Oncology, Immunology, Neurology, Infectious Disease, Rare Disease, Dermatology, Women's Health
Phase I, Phase II, Phase III, Phase IV, Preclinical (General), Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Headquarters, Morrisville, NC, United States, Southbank, Southbank, VIC, Australia, Sofia, Sofia, Bulgaria, Toronto, Mississauga, ON, Canada, Prague, Praha, Czech Republic, Paris, Paris, France, Darmstadt, Darmstadt, Germany, Budapest, Budapest, Hungary, Bengaluru, Bengaluru, India, Auckland, Auckland, New Zealand, Warsaw, Warszawa, Poland, Bucharest, Bucharest, Romania, Bratislava, Bratislava, Slovakia, Seoul, Seoul, South Korea, Madrid, Madrid, Spain, Taipei, Taipei, Taiwan, Kyiv, Kyiv, Ukraine, Wokingham, Wokingham, Berkshire, United Kingdom
—
High-Throughput Screening, Medicinal Chemistry, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research, Microbiology Services, Virology Services, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Device & Combination Product Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Oligonucleotide, Cell Therapy, Gene Therapy, Peptide, Vaccine, Radiopharmaceutical
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Ophthalmology, Gastroenterology
Preclinical (General), Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Headquarters, Hangzhou, Zhejiang, China, Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
—
Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Preclinical In Vivo Studies, In Vivo PK / PD Studies, GLP Toxicology, Bioanalysis, Biomarker Assays, Flow Cytometry Services, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Regulatory Affairs, US FDA Regulatory Strategy, Genomics & Sequencing Services
Small Molecule, Biologics (Other), Cell Therapy, Gene Therapy, Vaccine
Oncology, Immunology, Metabolic, Infectious Disease, Dermatology, Women's Health
Preclinical (General), Preclinical (IND-Enabling), Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO)
Delaware, Delaware, Delaware, USA, Miami, Miami, Florida, USA, Missouri, Missouri, Missouri, USA, The Netherlands, The Netherlands, The Netherlands, Netherlands, Austria, Austria, Austria, Austria, CTPS, Taiwan, Taiwan, Taiwan, NKSP, Taiwan, Taiwan, Taiwan, Qualitix, Taiwan, Taiwan, Taiwan, India, India, India, India
CLIA · ID: CLIA
Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Microbiology Services, Virology Services, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Device & Combination Product Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine, Radiopharmaceutical
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Phase I, Phase II, Phase III, Phase IV
Full-Service Outsourcing (FSO)
Central Laboratories, Cincinnati, Ohio, United States, Central Laboratory, Cincinnati, Ohio, United States, Headquarters, Cincinnati, OH, USA, Dallas, Irving, TX, USA, Denver, Denver, CO, USA, Mexico City, Mexico City, Distrito Federal, Mexico, Leuven, Leuven, Flemish Brabant, Belgium, Prague, Prague, Prague, Czech Republic, Copenhagen, Copenhagen, Copenhagen, Denmark, Lyon, Lyon, Auvergne-Rhône-Alpes, France, Munich, Munich, Bavaria, Germany, Budapest, Budapest, Budapest, Hungary, Rehovot, Rehovot, Central, Israel, Milan, Milan, Lombardy, Italy, London, London, England, United Kingdom, Maastricht, Maastricht, Limburg, Netherlands, Rotterdam, Rotterdam, South Holland, Netherlands, Warsaw, Warsaw, Masovian, Poland, Johannesburg, Johannesburg, Gauteng, South Africa, Dallas, Dallas, TX, USA, Madrid, Madrid, Spain, Mexico, Mexico City, Mexico City, Mexico
—
Showing three peers in the matrix — full ranked list is above.